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ABSTRACT: In our article, we asked whether Sox2, a transcription factor important in brain development and disease, is involved in gene regulation
through its action on long-range interactions between promoters and distant enhancers. Our findings highlight that Sox2 shapes a genome-wide network
of promoter-enhancer interactions, acting by direct binding to these elements. Sox2 loss affects the three-dimensional (3D) genome and decreases
the activity of a subset of genes involved in Sox2-bound interactions. At least one of such downregulated genes, Socs3, is critical for long-term neural
stem cell maintenance. These results point to the possibility of identifying a transcriptional network downstream to Sox2, and involved in neural stem cell
maintenance. In addition, interacting Sox2-bound enhancers are often connected to genes which are relevant, in man, to neurodevelopmental disease;
this may facilitate the detection of functionally relevant mutations in regulatory elements in man, contributing to neural disease.
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Identifying genes involved in neurodevelopmental defects is a
major ongoing endeavor. Previously, catalogs of human brain
enhancers and of polymorphisms within them have been produced and used to identify potential connections to schizophrenia and autism.1–4 On the other hand, genes functionally
connected to these enhancers have just begun to be defined.5 In
our article,6 we started to identify functional connections between
genes and enhancers in the mouse genome, with a view to provide
a basis for analysis of neural disease-relevant genes in humans.

Sox2 Function in the Transcriptional Regulation of
Neural Cell Identity and Disease

We focused on the roles of the transcription factor Sox2 in regulating the genome-wide interactions between genes and enhancers, thus shaping the global three-dimensional (3D) interactome.6
Sox2 is necessary for the maintenance of both embryonic stem
cells (ESCs)7 and neural stem cells (NSCs), both in vivo and in
vitro.8 In man, Sox2 mutation results in hippocampal defects, eye
defects, intellectual disability, and other neural defects.

The Role of Noncoding Elements in Regulating
Development and Disease

Extensive effort has identified thousands of active enhancers in
human and mouse neural cells using DNase sensitivity or chromatin immunoprecipitation of genomic sequences, bound by
p300 or modified histones like H3K27ac, coupled with sequencing (ChIP-seq). These foundational atlases of neural enhancer
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identities have been a major contribution to the field of neural
development and disease, but these studies did not reveal the
specific gene promoter(s) that are directly regulated by each
enhancer. Indeed, interactions between enhancers and promoters cannot be understood using the aforementioned approaches,
as these methods can only delineate the linear location of active
enhancers along the length of a chromosome. However, the
mammalian genome is organized in three dimensions through a
complex looping arrangement that is relevant to transcriptional
regulation.1,9 Inside the nucleus, chromosomes are extensively
folded into chromatin loops that occupy distinct 3D territories.
This highly organized 3D chromatin organization provides a
topological basis for many genome functions, including transcription, by bringing distal regulatory elements and their cognate genes into close spatial proximity.9 Chromatin organization
and enhancer-promoter interactions are highly dynamic during
lineage specification.10,11 Long-range interactions connect
genes (or gene promoters) to other promoters (promoter-promoter interactions), or to distant regions (promoter-enhancer
interactions) carrying enhancer marks, often skipping other
intervening genes.

The Use of Chromatin Interaction Assays in WildType and Sox2-Deleted Brain-Derived NSC to
Determine Sox2-Associated Interactions

At the genome level, these interactions (interactome) have
been extensively characterized by techniques such as HiC and
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Chromatin Interaction Analysis by Paired-End-Tag sequencing (ChIA-PET), which rely on the detection, by highthroughput sequencing, of proximity ligated DNA fragments
within fragmented fixed chromatin.2,9,11,12 These studies provided extensive catalogs of potential enhancers (and polymorphism within them), connected in various tissues to specific
genes. At the genome-wide level, the regulatory functions of
the detected enhancers and interactions have been so far
addressed by few previous studies.2,5,12
We adopted RNApolII ChIA-PET (as well as an improved
version of it, “in situ ChIA-PET”) to capture genome-wide
chromatin interactions between genes and enhancers that are
associated with RNA polymerase II (RNAPII) and, concomitantly, to identify previously unrecognized enhancer elements
in the mouse genome. We thus analyzed mouse brain-derived
wild-type and Sox2-mutant neonatal NSC grown in vitro
(Figure 1A). In parallel, we identified the genome-wide localization of DNA-bound Sox2, together with regions carrying
histone modifications indicative of enhancer activity
(H3K27Ac; H3K4me1). Overall, Sox2-bound interactions are
about 36% to 46% of the total interactions, pointing to a potential role of Sox2 in the generation or maintenance of the NSC
interactome. DNA-bound Sox2 is highly enriched within
“enhancer regions” genome-wide; in particular, the proportion
of total Sox2-bound “enhancers” that are represented within
DNA fragments (anchors) involved in promoter-enhancer
interactions is much higher than that of non-Sox2-bound
“enhancer regions” (Figure 1B), pointing to a potential role of
Sox2 specifically at the level of these interactions.

Sox2 Deletion Profoundly Affects the Pattern of
Interactions in Neonatal NSC

In neonatal cultures obtained from the brain of mice in which
Sox2 had been deleted during embryogenesis, the interactions
are, in general, greatly reduced: some are largely lost, whereas
others are less importantly affected in frequency (Figure 1A).
The strong decrease in the frequency of some of the interactions is indicative of a complete loss in a significant proportion
of the cells.
The parallel study of the transcriptome indicates that Sox2deleted cells show significantly decreased expression of some
700 genes. We looked for a correlation between the type of
interaction identified for each downregulated gene, and its
belonging to the category of genes that are downregulated in
mutant NSC, versus nondownregulated genes. The “downregulated genes in mutant” category is quite significantly enriched
in promoter-enhancer interactions, and even more in promoter-Sox2+ enhancer interactions (in wild-type cells),
whereas the “nondownregulated” category shows anticorrelation with these characteristics (Figure 1C). These results indicate that the activities of a significant fraction of genes are
dependent on their interaction with an enhancer, in particular
an Sox2-bound enhancer. Note that Sox2 deletion causes significant alterations of the expression of several transcription
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factors, which might in turn contribute to the changes in the
interactome; so, the observed correlation of gene downregulation (in mutant cells) with gene interactions with Sox2-bound
enhancers (in wild type cells) emerges on top of a background
of effects not directly dependent on Sox2.
A similar analysis shows that promoter-promoter interactions do not importantly affect the expression of genes in NSC,
although their loss may correlate with minor decreases of
expression in a subset of genes. Overall, our results stress the
importance of promoter-enhancer interactions for transcriptional regulation and indicate that the predominant functional
effect of Sox2 on gene transcription is exerted by its binding to
distal enhancers connected to regulated genes, rather than to
promoters.
It is presently unclear whether Sox2 acts directly to bring
about an interaction. It is possible that Sox2 acts by recruiting
other transcription factors, generating complexes which form
bridges connecting different DNA regions; additionally, Sox2
might interact with structural factors able to create/maintain
loops. YY1, a noncell type-specific factor, promotes the formation of a tissue-specific interactome in neural cells by binding
to specific sequences13: it is tempting to speculate that YY1
may collaborate with Sox2 in these processes. It will be interesting to identify the binding of additional transcription factors
in the proximity of Sox2 bound to anchors.
A large proportion of the genes involved in interactions
with enhancers maintain their activity even after Sox2 loss;
moreover, alterations in chromatin epigenetic marks are not
detected in Sox2-deleted cells. There are several possible explanations: (1) many genes have multiple interactions, and the
more interactions a gene has, the greater its activity (on average). As not all of the interactions centered on a given gene are
necessarily lost in Sox2-deleted cells, it is possible that the
remaining interactions are sufficient to confer significantly
high activity; (2) the maintenance of an “active gene” epigenetic
configuration might contribute to preserve gene activity. This
hypothesis implies that Sox2 might be required for the establishment of the active chromatin configuration, and of gene
activity, that might then be maintained, upon later deletion of
Sox2, by additional mechanisms (eg, binding of other transcription factors recruited by the initial Sox2 binding); (3)
interactions detected by ChIA-PET might represent a “snapshot” of a process (chromatin connectivity) that may be
dynamic; (some) interactions might be successively in an “off ”
or “on” state, in which case, loss of Sox2 might simply have
altered (ie, decreased) the probability of persisting in, or entering into, the “on” state (resulting in the observed overall decrease
of interactions).

Identification of Critical Genes for Sox2-Dependent
NSC Maintenance

Why do Sox2-deleted NSC lose the ability to self-renew? We
looked for genes that are likely directly regulated by Sox2 (ie,
bound by Sox2 at the enhancer or promoter in NSC, or
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Figure 1. Sox2-dependent interactions: (A) promoter-enhancer and promoter-promoter interactions are depicted in wild-type (top) and Sox2-deleted
(bottom) NSC. Red indicates interactions decreased in mutant cells. (B) Sox2 binding overlaps with H3K27Ac+ nucleosomes (“enhancers”). The
proportion of Sox2+ enhancers in interactions is much higher than the proportion of Sox2– enhancers (see text). (C) The loss of Sox2 from enhancers
involved in promoter-enhancer interactions is the major factor responsible for downregulation of the connected gene. (D) Is loss of long-range interactions
in Sox2-deleted NSC rescued by re-addition of Sox2, together with long-term self-renewal?

stimulated by Sox2 in transgenic zebrafish assays), and that lose
a large part of their expression in Sox2-deleted cells. Among
several genes sharing these characteristics, we identified Socs3

(suppressor of cytokine signaling), whose deletion is known to
favor diversion of NSC into the glial differentiation pathway.6
We then transduced Socs3, together with a green fluorescent
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Figure 2. Long-range Sox2-bound interactions and human-inherited neurodevelopmental disease: (A) functional enhancers connected to mouse
homologs of human neural disease genes may provide a clue to the identification of mutation/polymorphism in conserved human enhancers, responsible
for disease. (B) Mouse homologs of genes involved in neurodevelopmental disease in man are significantly enriched in Sox2-bound promoter-enhancer
interactions. Different types of microcephaly and intellectual disability are indicated. The proportion of Sox2-bound (red) to total genes considered (blue)
is indicated (see Bertolini et al,6 Table S6). (C) Screenshots of interactions involving the PTEN-induced kinase 1 (PINK1) and Presenilin-2 (Psen2) genes,
involved in Parkinson’s and Alzheimer’s disease, respectively.

protein (GFP) reporter gene, into Sox2-deleted NSC; this
resulted in a progressive increase of the proportion of GFP+
cells, up to almost 100%, and the efficient long-term

maintenance of the growth of these cells, well beyond the time
when untransduced Sox2-deleted cells had all been lost from
the culture. It is likely that additional genes will be identified by
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Figure 3. Two models for aggregated chromatin interactions.

similar screens; these might either cooperate with Socs3, or
might represent genes upstream to Socs3, and active, together
with Sox2, on Socs3 regulation, thus defining a network of
Sox2-dependent functional interactions.
The fact that Socs3 transduction rescues the maintenance of
Sox2-deleted NSC raises the interesting question whether the
altered long-range interactions pattern, and the correct gene
expression levels, can be restored to normal in rescued Sox2deleted NSC. Initial work indicates that Sox2 transduction is
also able to rescue NSC self-renewal; thus, the loss of selfrenewal is reversible in Sox2-deleted cells. ChIA-PET experiments will address the issue of restoration of the correct
interactome in these cells (Figure 1D).

brain enhancers identified in our studies show one or more of
these characteristics: (1) they stimulate forebrain expression of
a reporter gene in zebrafish; (2) they coincide with enhancers
active in early forebrain development in mouse14; and (3) they
are highly significantly connected to genes whose human
homologs are responsible, when mutated, for intellectual disability, microcephaly, vision disorders, Alzheimer and Parkinson
diseases, and so on (Figure 2). The large catalog of the presently
identified mouse distal “enhancers” may allow to look for mutations and polymorphisms in the corresponding human enhancers (if conserved) to facilitate the search for genetic variation
responsible for brain inherited disease and for predisposition to
schizophrenia and autism spectrum disorders.

Human Neural Disease-Relevant Gene Regulatory
Networks and Identification of Functional Neural
Enhancers

Perspectives for More In-depth Studies of the
Functional Interactome

Our data offer an exciting potential strategy to identify pathogenic noncoding variants affecting the function of their connected genes involved in neural diseases in man. Many of the

While HiC and ChIA-PET provide an extensive catalog of
(potentially) all the interactions, they have some limitations.
These techniques detect multiple gene promoters brought
together through chromatin interactions from the collection of
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large number of cells. Two different models can account for
these aggregated chromatin interactions: specific, pairwise promoter-enhancer interactions, or multivalent, in parallel chromatin interactions between different promoters and multiple
regulatory modules. That is, the enhancer activity could be target-specific, combinatorial, or both (Figure 3). Moreover, some
of the region-specific interactions are identified by large numbers of sequencing reads, whereas other interactions are rare; the
latter ones are likely present only in a small proportion of the
cells in the population. An assessment of functional roles of the
interaction would ideally require the knowledge of which interactions are present simultaneously on each gene region in a
given cell. Such an analysis has been made recently possible (in
Drosophila cells) by a new technique (ChIA-Drop).15 In ChIADrop, individual chromatin complexes are partitioned into
droplets with single gel bead containing unique DNA-barcoded
primers, such that all the chromatin fragments within each
droplet have the same barcodes and can be distinguished following linear amplification. The amplified barcoded DNAs are
then pooled for high-throughput sequencing. Sequencing reads
having identical barcodes are grouped as multivalent and represent combinatorial chromatin interactions between each
enhancers with all corresponding genes targets (Figure 3) which
identifies fragments present within single “drops” containing
individual chromatin fragments from single cells.15 If this technique can be applied to mouse or human cells, it will allow additional understanding of the function of the interactome. This
will be particularly interesting when analyzing the simultaneous
interactions of the enhancer component, revealing whether
interaction of a given enhancer is, at any specific time, limited to
a single gene, or extended to multiple different genes.

Acknowledgements

The authors thank the members of their laboratories and
their collaborators (in particular S. Ottolenghi, G. Pavesi, P.
Bovolenta) for discussion and support.

Author Contributions

SKN and CLW wrote the article; MP and YZ (who had done
fundamental experiments in the discussed research paper) discussed the article, and prepared the Figures.

ORCID iD

Silvia K Nicolis
References
1.

2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

https://orcid.org/0000-0003-0378-3808

Nord AS, Pattabiraman K, Visel A, Rubenstein JLR. Genomic perspectives of
transcriptional regulation in forebrain development. Neuron. 2015;85:27-47.
Won H, de la Torre-Ubieta L, Stein JL, et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature. 2016;538:
523-527.
The PsychENCODE Consortium. Revealing the brain’s molecular architecture.
Science. 2018;362:1262-1263.
Turner TN, Eichler E. The role of de novo noncoding regulatory mutations in
neurodevelopmental disorders. Trends Neurosci. 2019;42:115-127.
Gasperini M, Hill AJ, McFaline-Figueroa JL, et al. A genome-wide framework
for mapping gene regulation via cellular genetic screens. Cell. 2019;176:377-390.
e19.
Bertolini JA, Favaro R, Zhu Y, et al. Mapping the global chromatin connectivity
network for Sox2 function in neural stem cell maintenance. Cell Stem Cell.
2019;24:462-476.e6.
Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function.
Genes Dev. 2003;17:126-140.
Favaro R, Valotta M, Ferri AL, et al. Hippocampal development and neural
stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci.
2009;12:1248-1256.
Stadhouders R, Filion G, Graf T. Transcription factors and 3D genome conformation in cell-fate decisions. Nature. 2019;569:345-354.
Dixon JR, Jung I, Selvaraj S, et al. Chromatin architecture reorganization during
stem cell differentiation. Nature. 2015;518:331-336.
Zhang Y, Wong CH, Birnbaum RY, et al. Chromatin connectivity maps reveal
dynamic promoter-enhancer long-range associations. Nature. 2013;504:
306-310.
Tang Z, Luo OJ, Li X, et al. CTCF-mediated human 3D genome architecture
reveals chromatin topology for transcription. Cell. 2015;163:1611-1627.
Beagan JA, Duong MT, Titus KR, et al. YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment. Genome Res.
2017;27:1139-1152.
Visel A, Blow MJ, Li Z, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature. 2009;457:854-858.
Zheng M, Tian SZ, Capurso D, et al. Multiplex chromatin interactions with
single-molecule precision. Nature. 2019;566:558-562.

